Abstract
Early onset of substance use leads to a higher risk of developing psychosocial problems and a lifelong substance use disorder, which makes screening, prevention, and early intervention instrumental in moderating potential harm. Substance use can be viewed along a continuum from experimentation to problematic substance use and to mild, moderate, and severe substance use disorders. Nonmedical use of prescription medications also operates under a similar continuum and is particularly relevant to the adolescent age group since prescription medications may be more available to young people in some settings than are other substances. This chapter discusses key revisions from the DSM-IV to the DSM-5 and briefly explains how shifts in the diagnostic process impact the implementation of various screening tools. Evidence-based screening instruments are presented and described in detail. Additional health screening recommendations are outlined due to the high-risk behaviors associated with substance use.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Poudel A, Gautam S. Age of onset of substance use and psychosocial problems among individuals with substance use disorders. BMC Psychiatry. 2017;17(1):10.
Bava S, Thayer R, Jacobus J, Ward M, Jernigan TL, Tapert SF. Longitudinal characterization of white matter maturation during adolescence. Brain Res. 2010;1327:38–46.
American Psychiatric Association. DSM-IV-TR. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC. Substance-related disorders. 2000;191–297.
American Psychiatric Association. DSM-5. Diagnostic and statistical manual of mental disorders 5th ed. Substance-related and addictive disorders. 2013;481–589.
Rahim M, Patton R. The association between shame and substance use in young people: a systematic review. PeerJ. 2015;3:e737.
Kelly JF, Westerhoff CM. Does it matter how we refer to individuals with substance-related conditions? A randomized study of two commonly used terms. Int J Drug Policy. 2010;21(3):202–7.
Ramirez J, Miranda R. Alcohol craving in adolescents: bridging the laboratory and natural environment. Psychopharmacology. 2014;231(8):1841–51.
Agrawal A, Heath AC, Lynskey MT. DSM-IV to DSM-5: the impact of proposed revisions on diagnosis of alcohol use disorders. Addiction. 2011;106(11):1935–43.
Hasin DS, Fenton MC, Beseler C, Park JY, Wall MM. Analyses related to the development of DSM-5 criteria for substance use related disorders: 2. Proposed DSM-5 criteria for alcohol, cannabis, cocaine and heroin disorders in 663 substance abuse patients. Drug Alcohol Depend. 2012;122(1–2):28–37.
Slade EP, Stuart EA, Salkever DS, Karakus M, Green KM, Ialongo N. Impacts of age of onset of substance use disorders on risk of adult incarceration among disadvantaged urban youth: a propensity score matching approach. Drug Alcohol Depend. 2008;95(1–2):1–13.
Committee on Substance Use and Prevention. Substance use screening, brief intervention, and referral to treatment. Pediatrics. 2016;138(1):e20161210.
Pilowsky DJ, Wu L-T. Screening instruments for substance use and brief interventions targeting adolescents in primary care: a literature review. Addict Behav. 2013;38(5):2146–53.
Committee on Practice and Ambulatory Medicine, Bright Futures Periodicity Schedule Workgroup. 2017 recommendations for preventive pediatric health care. Pediatrics American Academy of Pediatrics. 2017;139(4):e20170254.
Wilson CR, Sherritt L, Gates E, Knight JR. Are clinical impressions of adolescent substance use accurate? Pediatrics. 2004;114(5):e536–40.
Kelly TM, Donovan JE, Chung T, Bukstein OG, Cornelius JR. Brief screens for detecting alcohol use disorder among 18-20 year old young adults in emergency departments: comparing AUDIT-C, CRAFFT, RAPS4-QF, FAST, RUFT-cut, and DSM-IV 2-item scale. Addict Behav. 2009;34(8):668–74.
Knight JR, Sherritt L, Harris SK, Gates EC, Chang G. Validity of brief alcohol screening tests among adolescents: a comparison of the AUDIT, POSIT, CAGE, and CRAFFT. Alcohol Clin Exp Res. 2003;27(1):67–73.
Cook RL, Chung T, Kelly TM, Clark DB. Alcohol screening in young persons attending a sexually transmitted disease clinic. Comparison of AUDIT, CRAFFT, and CAGE instruments. J Gen Intern Med. 2005;20(1):1–6.
Dhalla S, Zumbo BD, Poole G. A review of the psychometric properties of the CRAFFT instrument: 1999–2010. Curr Drug Abuse Rev. 2011;4(1):57–64.
D’Amico EJ, Parast L, Meredith LS, Ewing BA, Shadel WG, Stein BD. Screening in primary care: what is the best way to identify at-risk youth for substance use? Pediatrics. 2016;138(6):e20161717.
Mitchell SG, Kelly SM, Gryczynski J, Myers CP, O’Grady KE, Kirk AS, et al. The CRAFFT cut-points and DSM-5 criteria for alcohol and other drugs: a reevaluation and reexamination. Subst Abus. 2014;35(4):376–80.
Skogen JC, Bøe T, Knudsen AK, Hysing M. Psychometric properties and concurrent validity of the CRAFFT among Norwegian adolescents. Ung@hordaland, a population-based study. Addict Behav. 2013;38(10):2500–5.
Kandemir H, Aydemir Ö, Ekinci S, Selek S, Kandemir SB, Bayazit H. Validity and reliability of the Turkish version of CRAFFT substance abuse screening test among adolescents. Neuropsychiatr Dis Treat. 2015;11:1505–9.
Wartberg L, Kriston L, Diestelkamp S, Arnaud N, Thomasius R. Psychometric properties of the German version of the CRAFFT. Addict Behav. 2016;59:42–7.
Harris SK, Johnson JK, Sherritt L, Copelas S, Rappo MA, Wilson CR. Putting adolescents at risk: riding with drinking drivers who are adults in the home. J Stud Alcohol Drugs. 2017;78(1):146–51.
U.S. Department of Transportation, National Highway Traffic Safety Administration (NHTSA). Traffic safety facts 2014. https://crashstats.nhtsa.dot.gov/Api/Public/Publication/812261. Accessed 23 July 2018.
Levy S, Weiss R, Sherritt L, Ziemnik R, Spalding A, Van Hook S, et al. An electronic screen for triaging adolescent substance use by risk levels. JAMA Pediatr. 2014;168(9):822–8.
Subramaniam GA, Volkow ND. Substance misuse among adolescents. JAMA Pediatr. 2014;168(9):798.
Knight JR, Harris SK, Sherritt L, Van Hook S, Lawrence N, Brooks T, et al. Adolescents’ preference for substance abuse screening in primary care practice. Subst Abus. 2007;28(4):107–17.
Harris SK, Csémy L, Sherritt L, Starostova O, Van Hook S, Johnson J, et al. Computer-facilitated substance use screening and brief advice for teens in primary care: an international trial. Pediatrics. 2012;129(6):1072–82.
Richardson LP, Rockhill C, Russo JE, Grossman DC, Richards J, McCarty C, et al. Evaluation of the PHQ-2 as a brief screen for detecting major depression among adolescents. Pediatrics. 2010;125(5):e1097–103.
Services USD of H and H. Mandatory guidelines for federal workplace drug testing. Subst Abus Ment Heal Serv Adm. 2004;69(71):1.
Levy S, Siqueira LM. Testing for drugs of abuse in children and adolescents. Pediatrics. 2014;133(6):e1798–807.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Schram, J.W., Schram, P.C.F., Knight, J.R. (2019). Screening for Substance Use and Associated Medical Conditions. In: Welsh, J., Hadland, S. (eds) Treating Adolescent Substance Use. Springer, Cham. https://doi.org/10.1007/978-3-030-01893-1_3
Download citation
DOI: https://doi.org/10.1007/978-3-030-01893-1_3
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-01892-4
Online ISBN: 978-3-030-01893-1
eBook Packages: MedicineMedicine (R0)